AGL vs KIDS

The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of 4/9, indicating borderline stability, and a missing Altman Z-Score prevents a full distress risk assessment. Profitability metrics are deeply negative, including a -5.24% profit margin, -8.86% operating margin, and a disastrous -73.31% ROE, signaling severe capital inefficiency. Despite a low Price/Sales ratio of 0.07 and a current price of $0.99, the company is unprofitable with declining revenue and negative earnings momentum, while the market has priced in extreme pessimism, as seen in a 5Y return of -96.8%. Analysts unanimously recommend a 'hold' with a target price equal to the current price, suggesting no near-term upside expectation.

The company exhibits severe fundamental weakness, highlighted by a Piotroski F-Score of 1/9, indicating poor financial health and operational efficiency. While OrthoPediatrics maintains a strong gross margin (73.05%) and excellent liquidity (Current Ratio 5.55), it has failed to achieve profitability over 25 consecutive quarters. This chronic lack of earnings, combined with a bearish technical trend and significant insider selling by the CEO and COO, suggests a high-risk profile. Despite revenue growth of 17%, the inability to convert sales into net income makes the current valuation speculative.